Will Emcure’s Eribilin be a ray of hope?
At approximately 40 per cent of the cost of the innovator, Emcure Pharma’s Eribilin is definitely a more cost effective alternate…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
GST on promotional schemes – A quandary for pharma sector
Jigar Doshi, Executive Director | Partner – Indirect Taxes, SKP Business Consulting, explains how despite bringing in monumental…
The ingredient for success
As India’s only manufacturer and one of the top few global manufacturers of Vitamin D3, Fermenta Biotech has a very interesting…
Clinical trials: Breaking the taboo
India’s share of global clinical trials, minuscule to start with, has seen a steady decline from 1.5 per cent a few yearsback to…
‘One should always buy generic medicines from reliable brands or outlets’
Having an idea to serve the populace with inexpensive but effective medicine, StayHappi Pharmacy wants to reach as many people as…
Packaging: Connecting product with people
Globalisation and consumerisation have not only helped to enhance the scale of operations, but also helped in enhancing the…
Driving value from genomics in life sciences
Genomics can bring significant benefits to healthcare systems, by accelerating clinical research and drug development,…
Our ambition is to change attitudes and make uninhibited living a habit
Nikhil Chopra, India Business Head, Cipla speaks on busting myths on asthma and Ciplas' #BerokZindagi initiative to lead a better…
GMI Research publishes Global Neurostimulation Market report
Provides in-depth analysis of neurostimulation market across the globe
Development progress in 2018 for acute ischemic stroke drugs will fuel market growth
Novel drugs designed to improve clinical outcomes of AIS patients will start launching from 2021
How will 2019 unfold for pharma business?
Dr RB Smarta, MD, Interlink Marketing Consultancy shares his insights on how the pharma industry will evolve this year and…
New growth tonic for Indian pharma industry
Rishabh Bindlish, MD – AAPAC Life Sciences Lead, Accenture Strategy, advises that pharma companies need to tighten their belts…
The rotten pill
With technological advancements, pharma companies can also explore new generation anti-counterfeiting technologies. In the last of…
Recommendations and way forward for Indian biosimilars industry: Road to a sustainable future
A research paper from Sathguru Consultants offers recommendations to nurture the vibrant biosimilars industry landscape and…
A race to the bottom on price must not mean low quality, high volumes
Professor (Dr) Hilary Thomas, Partner and Chief Medical Officer - Healthcare and Life Sciences Advisory and Global Centre of…
Monitoring product safety beyond clinical trials – Industry practices
Dr J Vijay Venkatraman, Managing Director & CEO, Oviya MedSafe, details on the need to foster adherence to good…
The Pill House
Pill House or the pharmacy forms an integral part of the healthcare system. Pharmacies with well-organised practice can go a long…
Building an effective sales pipeline
Mohan G Joshi, International Business Coach and Former President, SCHOTT Glass India outlines the importance of measuring the…
‘Under GDUFA II, FDA has committed to clean up inaccurate, inconsistent and missing…
DuPont Nutrition & Health's regulatory team, from direct participation on joint IPEC and FDA working groups, has the expertise…
AI in pharma: A new perspective
Dipankar Kaul -Head GMP Audits, Asia-Pacific- Novartis Technical Operations, envisages the many ways in which AI can transform…